M&A Deal Summary

Servier Acquires CTI BioPharma - PIXUVRI

On October 1, 2019, Servier acquired life science company CTI BioPharma - PIXUVRI from CTI BioPharma

Acquisition Highlights
  • This is Servier’s 1st transaction in the Life Science sector.
  • This is Servier’s 1st transaction in the United States.
  • This is Servier’s 1st transaction in Washington.

M&A Deal Summary
Date 2019-10-01
Target CTI BioPharma - PIXUVRI
Sector Life Science
Buyer(s) Servier
Sellers(s) CTI BioPharma
Deal Type Divestiture

Target

CTI BioPharma - PIXUVRI

Seattle, Washington, United States
CTI BioPharma Corp. - PIXUVRI is a cytotoxic medicine that works by interfering with the DNA within cells and preventing them from making more copies of DNA.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Servier

Suresnes, France
Category Company
Founded 1954
Sector Life Science
Employees22,000
Revenue 4.2B EUR (2018)
DESCRIPTION

Servier is a pharmaceutical company governed by a non-profit foundation. Servier’s constant search for innovation in five areas of excellence: cardiovascular, immune-inflammatory and neurodegenerative diseases, cancer and diabetes, as well as by its activities in high-quality generic drugs. Servier also offers eHealth solutions beyond drug development. Servier was founded in 1954 and is based in Suresnes, France.

DEAL STATS #
Overall 1 of 3
Sector (Life Science) 1 of 3
Type (Divestiture) 1 of 2
State (Washington) 1 of 1
Country (United States) 1 of 2
Year (2019) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-06-04 Symphogen AS

Ballerup, Denmark

Symphogen AS is a polyclonal antibody technology that provides a totally new, innovative class of biopharmaceuticals for treating serious human diseases. Symphogen was founded in 2000 and is based in Ballerup, Denmark.

Buy -

Seller(S) 1

SELLER

CTI BioPharma

Seattle, Washington, United States
Category Company
Founded 1991
Sector Life Science
Employees144
Revenue 54M USD (2022)
DESCRIPTION

CTI is a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related cancers that offer a unique benefit to patients and their healthcare providers. CTI BioPharma was founded in 1991 and is based in Seattle, Washington.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
State (Washington) 1 of 1
Country (United States) 1 of 1
Year (2019) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-07-31 Systems Medicine

Tucson, Arizona, United States

Systems Medicine, Inc. is a privately held oncology company produces oncology products.

Buy -
Mergr

Product

Company

Legal